News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,775 Results
Type
Article (2366)
Company Profile (39)
Press Release (34370)
Section
Business (14069)
Career Advice (76)
Deals (2069)
Drug Delivery (7)
Drug Development (4061)
Employer Resources (10)
FDA (423)
Job Trends (756)
News (20030)
Policy (1049)
Tag
Academia (143)
Africa (42)
Alliances (3433)
Alzheimer's disease (39)
Antibody-drug conjugate (ADC) (5)
Approvals (420)
Arizona (13)
Asia (1798)
Australia (291)
Bankruptcy (10)
Best Places to Work (465)
Biosimilars (9)
Biotechnology (31)
C2C Services and Suppliers (1966)
California (281)
Canada (52)
Cancer (27)
Career advice (64)
Cell therapy (9)
China (11)
Clinical research (3007)
Collaboration (19)
Colorado (5)
Compensation (10)
Connecticut (7)
COVID-19 (176)
C-suite (4)
Data (11)
Diagnostics (449)
Earnings (4048)
Employer resources (8)
Europe (3717)
Events (5733)
Executive appointments (16)
FDA (427)
Florida (12)
Funding (15)
Gene editing (7)
Gene therapy (6)
GLP-1 (44)
Government (145)
Healthcare (694)
Hotbed/Location (27278)
Illinois (11)
Indiana (14)
Infectious disease (176)
Inflammatory bowel disease (9)
Inflation Reduction Act (5)
Interviews (7)
IPO (962)
IRA (5)
Job creations (289)
Job search strategy (62)
Kansas (12)
Layoffs (31)
Legal (208)
Liver cancer (5)
Lung cancer (7)
Manufacturing (5)
Maryland (11)
Massachusetts (88)
Medical device (299)
Medtech (299)
Mergers & acquisitions (1114)
Metabolic disorders (10)
Minnesota (7)
Neuroscience (51)
New Jersey (9)
New York (17)
NextGen Class of 2024 (347)
Non-profit (152)
North Carolina (57)
Northern California (123)
Ohio (17)
Opinion (13)
Patents (9)
Pennsylvania (13)
People (5461)
Phase I (1288)
Phase II (1517)
Phase III (814)
Pipeline (6)
Policy (7)
Postmarket research (30)
Preclinical (563)
Radiopharmaceuticals (11)
Real estate (418)
Recruiting (5)
Regulatory (754)
Reports (5)
Research institute (141)
Resumes & cover letters (9)
Schizophrenia (5)
South America (40)
Southern California (135)
Startups (485)
Texas (11)
United States (605)
Vaccines (18)
Washington State (10)
Date
Today (7)
Last 7 days (34)
Last 30 days (169)
Last 365 days (2767)
2024 (1941)
2023 (2857)
2022 (3750)
2021 (4049)
2020 (3471)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
36,775 Results for "twinstrand biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
TwinStrand Biosciences Initiates Regulatory Approval Process for Duplex Sequencing Mutagenesis Assays with OECD
TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from genetic toxicology to residual cancer detection announces the successful acceptance of the standard project submission form (SPSF) by the Organization for Economic Cooperation and Development (OECD).
April 24, 2024
·
3 min read
Business
TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology
July 31, 2024
·
3 min read
BioForest
TwinStrand Biosciences Announces Executive Leadership Changes to Accelerate Adoption of Duplex Sequencing for Minimal Residual Disease (MRD) Testing for Hematological Malignancies and Cell Therapy Monitoring
TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from residual cancer detection to genetic toxicology announced the appointment of Ron Andrews, as Chief Executive Officer and Board Member.
August 29, 2023
·
4 min read
Business
TwinStrand Biosciences Announces Leadership Transition
TwinStrand Biosciences, Inc. today announced that the company has implemented a reorganization designed to sustain growth through a focus on key commercial initiatives.
October 7, 2022
·
3 min read
Business
TwinStrand Biosciences Expands Executive Team With Appointment of Goran Pljevaljcic as Chief Commercial Officer
TwinStrand Biosciences, Inc. today announced the appointment of Goran Pljevaljcic, Ph.D. as Chief Commercial Officer.
April 28, 2022
·
3 min read
BioForest
Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform
Singular Genomics Systems Inc. and TwinStrand Biosciences, Inc. announced a collaboration to develop highly sensitive next generation sequencing solutions for the Singular G4 Sequencing Platform for cutting-edge applications like minimal residual disease detection.
June 6, 2022
·
5 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Precision BioSciences Announces its Addition to the Russell Microcap® Index
Precision BioSciences, Inc. today announced its addition to the Russell Microcap® Index.
July 1, 2024
·
9 min read
Drug Development
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts
Genflow Biosciences Strengthens Pre-Clinical Efforts with FDA Guidance and CDMO and CRO Selection
June 27, 2024
·
6 min read
Marvel Biosciences Announces Private Placement Update
Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), wishes to announce that
June 21, 2024
·
2 min read
1 of 3,678
Next